← Insider buys
KRTX

Karuna Therapeutics, Inc.

Director Atul Pande sold $342K of Karuna Therapeutics, Inc.

Sold$341,675
$136.67Price
2,500Shares
−100%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Mon, Nov 1. Filed Wed, Nov 3, 4:14 PM ET, after the close. Not investment advice.